Premier Biomedical, Inc. (BIEI)

Market Cap	629.99K -18.1%
Revenue (ttm)	14.28K -64.1%
Net Income	-374.47K
EPS	-0.01
Shares Out	1.40B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	7,389,327
Open	0.0004
Previous Close	0.0004
Day's Range	0.0004 - 0.0004
52-Week Range	0.0003 - 0.0017
Beta	0.06
RSI	36.00
Earnings Date	n/a

About Premier Biomedical

Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil ca...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2010
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: BIEI

Financial Performance

In 2019, Premier Biomedical's revenue was $14,281, a decrease of -64.11% compared to the previous year's $39,795. Losses were -$374,470, -6.12% less than in 2018.